{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:32:02Z","timestamp":1760236322680,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001870","name":"Foundation for Polish Science","doi-asserted-by":"publisher","award":["POIR.04.04.00-00-420C\/17-02"],"award-info":[{"award-number":["POIR.04.04.00-00-420C\/17-02"]}],"id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-156-04\/503-11-001"],"award-info":[{"award-number":["503\/1-156-04\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Background: Recent studies suggest that lipids, including free fatty acids (FFAs), are necessary for proper \u03bc opioid receptor (MOR) binding and that activation of opioid receptors (ORs) improves intestinal inflammation. The objective of the study was to investigate a possible interaction between the ORs and FFA receptors (FFARs) ligands in the colitis. Methods: The potential synergistic effect of ORs and FFARs ligands was evaluated using mouse model of acute colitis induced by dextran sulfate sodium (DSS, 4%). Compounds were injected intraperitoneally (i.p.) once or twice daily at the doses of 0.01 or 0.02 mg\/kg body weight (BW) (DAMGO\u2014an MOR agonist), 0.3 mg\/kg BW (DPDPE\u2014a \u03b4 OR (DOR) agonist) and 1 mg\/kg BW (naloxone\u2014a non-selective OR antagonist, GLPG 0974\u2014a FFAR2 antagonist, GSK 137647\u2014a FFAR4 agonist and AH 7614\u2014a FFAR4 antagonist) for 4 days. Results: Myeloperoxidase (MPO) activity was significantly decreased after DAMGO (0.02 mg\/kg BW) and GSK 137647 (1 mg\/kg BW) administration and co-administration as compared to DSS group. Conclusions: Treatment with ligands of ORs and FFARs may affect the immune cells in the inflammation; however, no significant influence on the severity of colitis and no synergistic effect were observed.<\/jats:p>","DOI":"10.3390\/molecules26226827","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T23:04:46Z","timestamp":1636671886000},"page":"6827","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1173-2966","authenticated-orcid":false,"given":"Agata","family":"Binienda","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0695-9808","authenticated-orcid":false,"given":"Adam","family":"Makaro","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-1161","authenticated-orcid":false,"given":"Marcin","family":"Talar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia B.","family":"Krajewska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-3158","authenticated-orcid":false,"given":"Aleksandra","family":"Tarasiuk","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Bartoszek","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-4925","authenticated-orcid":false,"given":"Adam","family":"Fabisiak","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"},{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 93-281 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Mosi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Niewinna","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Dziedziczak","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miko\u0142aj","family":"\u015awierczy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radzis\u0142aw","family":"Kordek","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-8749","authenticated-orcid":false,"given":"Maciej","family":"Salaga","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8443-4417","authenticated-orcid":false,"given":"Jakub","family":"Fichna","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"ref_1","first-page":"83","article-title":"Pathogenesis of IBD","volume":"Volume 1","author":"Fichna","year":"2017","journal-title":"Introduction to Gastrointestinal Diseases"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/2050640614550672","article-title":"Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?","volume":"2","author":"Raine","year":"2014","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/17474124.2014.881715","article-title":"Adverse events in IBD: To stop or continue immune suppressant and biologic treatment","volume":"8","author":"McLean","year":"2014","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.cellsig.2006.03.011","article-title":"G protein-coupled receptors for free fatty acids","volume":"18","author":"Milligan","year":"2006","journal-title":"Cell. Signal."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4155\/fmc-2016-0205","article-title":"Fatty acid and mineral receptors as drug targets for gastrointestinal disorders","volume":"9","author":"Pongkorpsakol","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mnfr.200700289","article-title":"Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases","volume":"52","author":"Calder","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104604","DOI":"10.1016\/j.phrs.2019.104604","article-title":"Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases","volume":"152","author":"Bartoszek","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"90\u2013108.e5","DOI":"10.1016\/j.neuron.2018.03.002","article-title":"Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits","volume":"98","author":"Wang","year":"2018","journal-title":"Neuron"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Abdallah, K., and Gendron, L. (2017). The Delta Opioid Receptor in Pain Control. Handbook of Experimental Pharmacology, Springer.","DOI":"10.1007\/164_2017_32"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e00120","DOI":"10.14309\/ctg.0000000000000120","article-title":"Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases","volume":"11","author":"Kienzl","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_12","first-page":"5","article-title":"Release of endogenous opioids during a chronic IBD model suppresses the excitability of colonic DRG neurons","volume":"25","author":"Benson","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2013.00123","article-title":"Targeting pain and inflammation by peripherally acting opioids","volume":"4","author":"Stein","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI200316750","article-title":"Anti-inflammatory properties of the \u03bc opioid receptor support its use in the treatment of colon inflammation","volume":"111","author":"Philippe","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_15","first-page":"G544","article-title":"Inflammation-associated changes in DOR expression and function in the mouse colon","volume":"315","author":"DiCello","year":"2018","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1471-4159.1987.tb09987.x","article-title":"Lipid Requirement for \u03bc Opioid Receptor Binding","volume":"49","author":"Hasegawa","year":"1987","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.7455690","article-title":"Opiate antagonist improves neurologic recovery after spinal injury","volume":"211","author":"Faden","year":"1981","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3171\/jns.1983.58.5.0720","article-title":"Effects of naloxone on systemic and cerebral responses to experimental concussive brain injury in cats","volume":"58","author":"Hayes","year":"1983","journal-title":"J. Neurosurg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3793\u2013800","DOI":"10.1523\/JNEUROSCI.10-12-03793.1990","article-title":"Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism","volume":"10","author":"Bakshi","year":"1990","journal-title":"J. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/gutjnl-2019-320230","article-title":"Identification of new enterosynes using prebiotics: Roles of bioactive lipids and mu-opioid receptor signalling in humans and mice","volume":"70","author":"Abot","year":"2021","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.2174\/138161212803582513","article-title":"Non-Analgesic Effects of Opioids: Peripheral Opioid Effects on Inflammation and Wound Healing","volume":"18","author":"Stein","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2362.2010.02407.x","article-title":"Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD","volume":"41","author":"Kovarik","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10044","DOI":"10.1021\/jm5012885","article-title":"Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: From hit to clinic","volume":"57","author":"Pizzonero","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/bcp.12900","article-title":"Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects","volume":"82","author":"Namour","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8495913","DOI":"10.1155\/2019\/8495913","article-title":"The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease","volume":"2019","author":"Ma","year":"2019","journal-title":"Mediators Inflamm."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Marton, L.T., Goulart, R.A., de Carvalho, A.C.A., and Barbalho, S.M. (2019). Omega fatty acids and inflammatory bowel diseases: An overview. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194851"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"22207","DOI":"10.1074\/jbc.M115.703835","article-title":"Branched fatty acid esters of hydroxy fatty acids (FAHFAs) protect against colitis by regulating gut innate and adaptive immune responses","volume":"291","author":"Lee","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Salaga, M., Bartoszek, A., Binienda, A., Krajewska, J.B., Fabisiak, A., Mosi\u0144ska, P., Dziedziczak, K., Niewinna, K., Talar, M., and Tarasiuk, A. (2021). Activation of free fatty acid receptor 4 affects intestinal inflammation and improves colon permeability in mice. Nutrients, 13.","DOI":"10.3390\/nu13082716"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajpath.2014.09.010","article-title":"Tumor necrosis factor \u03b1 decreases glucagon-like peptide-2 expression by up-regulating G-protein-coupled receptor 120 in crohn disease","volume":"185","author":"Tsukahara","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm.3614","article-title":"A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice","volume":"20","author":"Oh","year":"2014","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.438","article-title":"Oral administration of the selective GPR120\/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases","volume":"6","author":"Wannick","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2013.03.006","article-title":"Targeting inflammation and wound healing by opioids","volume":"34","author":"Stein","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s13311-020-00937-z","article-title":"Novel Analgesics with Peripheral Targets","volume":"17","author":"Ciotu","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/nmo.12521","article-title":"Activation of \u03bc opioid receptors modulates inflammation in acute experimental colitis","volume":"27","author":"Anselmi","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2008.11.019","article-title":"Peripheral antinociceptive effects of \u00b5- and \u03b4 -opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic in fl ammatory pain","volume":"602","author":"Hervera","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/jpet.105.091991","article-title":"Antiexudative Effects of Opioids and Expression of \u03ba- and \u03b4- Opioid Receptors during Intestinal Inflammation in Mice: Involvement of Nitric Oxide","volume":"316","author":"Puig","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/164_2016_116","article-title":"Insights into the role of opioid receptors in the GI tract: Experimental evidence and therapeutic relevance","volume":"239","author":"Galligan","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00210-014-1025-x","article-title":"Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice","volume":"387","author":"Lewandowska","year":"2014","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/22\/6827\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:28:53Z","timestamp":1760167733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/22\/6827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":38,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["molecules26226827"],"URL":"https:\/\/doi.org\/10.3390\/molecules26226827","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2021,11,11]]}}}